Specify a stock or a cryptocurrency in the search bar to get a summary
Alkem Laboratories Limited
ALKEMAlkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India. Address: Alkem House, Mumbai, India, 400013
Analytics
WallStreet Target Price
410 816.51 INRP/E ratio
36.8994Dividend Yield
0.16 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ALKEM
Dividend Analytics ALKEM
Dividend growth over 5 years
169 %Continuous growth
7 yearsPayout Ratio 5 years average
28 %Dividend History ALKEM
Stock Valuation ALKEM
Financials ALKEM
Results | 2019 | Dynamics |